SCHEMBL29980892

SCHEMBL29980892

CNc1ccccc1CO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ AR P10275 1/20 0.45
▸ IDO1 P14902 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ APOBEC3G Q9HC16 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ ATM Q13315 1/20 0.41
▸ PDCD1 Q15116 1/20 0.41
▸ CD274 Q9NZQ7 1/20 0.41
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1066003 1.00 ALDH1A1 (0.47) ALDH1A1HPGDARIDO1KDM4E
SCHEMBL932125 0.82 TDP1 (0.40) ALDH1A1HPGDARIDO1KDM4E
SCHEMBL17724211 0.79 PDCD1 (0.40) ALDH1A1HPGDARIDO1KDM4E
SCHEMBL22567484 0.79 GPR35 (0.38) ALDH1A1HPGDARIDO1KDM4E
SCHEMBL3461978 0.79 TMEM97 (0.47) ALDH1A1HPGDARKDM4EPOLB
SCHEMBL5315930 0.79 TRPV1 (0.40) ALDH1A1HPGDARIDO1KDM4E
SCHEMBL1682034 0.78 ALDH1A1 (0.50) ALDH1A1HPGDARKDM4EPOLB
SCHEMBL7673743 0.77 IDO1 (0.50) ALDH1A1HPGDARIDO1POLB
SCHEMBL3461975 0.77 ALDH1A1 (0.36) ALDH1A1HPGDARIDO1KDM4E
SCHEMBL27603742 0.77 SLC16A3 (0.39) ALDH1A1HPGDARKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115298198-A Novel compounds and compositions for targeted therapy of kidney-related cancers 上海盟科药业股份有限公司 2022-11-04 — — CN disclosed
Send feedback